Company Sector
Hematology
Hematology includes companies focused on blood disorders, bone marrow disease, hemoglobinopathies, clotting disorders, and hematologic cancers. Businesses grouped here often sit at the intersection of rare disease, oncology, and precision medicine.
Why watch Hematology
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Hematology news
The latest feed items from companies currently grouped under Hematology.
- 01
- 02
- 03
SNDXSyndax Reports Second Quarter 2026 Financial Results and Provides Business Update
Source: Syndax Pharmaceuticals
- 04
RIGLRigel Reports Second Quarter 2026 Financial Results
Source: Rigel Pharmaceuticals
- 05
KPTIKaryopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Source: Karyopharm Therapeutics
- 06
- 07
PRPOPrecipio Announces Q2-2026 Shareholder Update Call
Source: Precipio Diagnostics
- 08
KPTIKaryopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway
Source: Karyopharm Therapeutics
- 09
KPTIKaryopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
Source: Karyopharm Therapeutics
- 10
- 11
RIGLRigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results
Source: Rigel Pharmaceuticals
- 12
SNDXSyndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
Source: Syndax Pharmaceuticals
- 13
APVOAptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
Source: Aptevo Therapeutics
- 14
- 15
- 16
- 17
- 18
SNDXSyndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event
Source: Syndax Pharmaceuticals
- 19
- 20
KPTIKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Karyopharm Therapeutics
Companies in Hematology
14 companies tagged with Hematology.
Frequently Asked Questions
What does the Hematology sector include?
Hematology includes companies focused on blood disorders, bone marrow disease, hemoglobinopathies, clotting disorders, and hematologic cancers. Businesses grouped here often sit at the intersection of rare disease, oncology, and precision medicine.
How many companies are currently tagged with Hematology?
14 companies are currently grouped under Hematology on BioPharmSignal.
Which companies are most visible in the Hematology group right now?
APVO, APTO, CASI, IRON are among the companies currently shown on this sector page.
How can I watch news for Hematology?
Use the Watch button on this page to subscribe to Hematology headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Hematology?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Hematology.